DexCom Historical Income Statement

DXCM Stock

USD 130.53 0.31 0.24%

Historical analysis of DexCom income statement accounts such as Operating Income of 627.6 M or Ebit of 767.2 M can show how well DexCom Inc performed in making a profits. Evaluating DexCom income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of DexCom's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining DexCom Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether DexCom Inc is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

About DexCom Income Statement Analysis

DexCom Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to DexCom shareholders. The income statement also shows DexCom investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

DexCom Income Statement Chart

DexCom Inc Income Statement is one of the three primary financial statements used for reporting DexCom's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of DexCom Inc revenue and expense. DexCom Income Statement primarily focuses on the company's revenues and expenses during a particular period.

At this time, DexCom's Net Income is very stable compared to the past year. As of the 23rd of May 2024, Income Tax Expense is likely to grow to about 177.3 M, while Total Other Income Expense Net is likely to drop (2.1 M).

Interest Expense Other Operating Expenses Ebit Research Development Total Operating Expenses Interest Income

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of DexCom Inc. It is also known as DexCom overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Most accounts from DexCom's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into DexCom Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

DexCom income statement Correlations

	Interest Expense	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Net Income	Income Tax Expense	Depreciation And Amortization	Selling General Administrative	Income Before Tax	Total Other Income Expense Net	Selling And Marketing Expenses	Total Revenue	Gross Profit	Cost Of Revenue	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Interest Expense		0.47	0.32	0.27	0.63	0.29	0.51	0.41	-0.38	0.36	0.44	0.2	0.19	0.4	0.46	0.48	0.41	0.42	0.21	-0.38	0.03	-0.55	0.37	0.69
Other Operating Expenses	0.47		0.89	0.9	0.94	0.91	1.0	0.86	0.42	0.87	1.0	0.33	0.3	0.97	1.0	1.0	0.99	0.87	0.65	0.42	0.78	0.34	0.9	0.86
Operating Income	0.32	0.89		0.99	0.71	0.98	0.85	0.97	0.4	0.87	0.89	0.16	0.13	0.94	0.93	0.92	0.94	0.97	0.5	0.4	0.86	0.5	0.87	0.68
Ebit	0.27	0.9	0.99		0.71	1.0	0.86	0.96	0.46	0.9	0.9	0.17	0.13	0.94	0.93	0.92	0.94	0.96	0.54	0.46	0.91	0.58	0.86	0.68
Research Development	0.63	0.94	0.71	0.71		0.73	0.97	0.7	0.28	0.76	0.93	0.36	0.33	0.88	0.91	0.93	0.89	0.71	0.6	0.28	0.57	0.08	0.81	0.91
Ebitda	0.29	0.91	0.98	1.0	0.73		0.87	0.95	0.46	0.93	0.9	0.18	0.15	0.95	0.93	0.92	0.95	0.95	0.53	0.46	0.92	0.58	0.85	0.69
Total Operating Expenses	0.51	1.0	0.85	0.86	0.97	0.87		0.82	0.39	0.84	0.99	0.35	0.32	0.96	0.99	0.99	0.98	0.83	0.64	0.39	0.72	0.27	0.89	0.88
Net Income	0.41	0.86	0.97	0.96	0.7	0.95	0.82		0.18	0.85	0.86	0.17	0.13	0.9	0.89	0.89	0.9	1.0	0.49	0.18	0.8	0.4	0.82	0.71
Income Tax Expense	-0.38	0.42	0.4	0.46	0.28	0.46	0.39	0.18		0.45	0.43	0.04	0.02	0.47	0.42	0.4	0.45	0.18	0.28	1.0	0.63	0.73	0.41	0.11
Depreciation And Amortization	0.36	0.87	0.87	0.9	0.76	0.93	0.84	0.85	0.45		0.85	0.23	0.2	0.91	0.88	0.88	0.89	0.85	0.45	0.45	0.9	0.54	0.74	0.66
Selling General Administrative	0.44	1.0	0.89	0.9	0.93	0.9	0.99	0.86	0.43	0.85		0.35	0.32	0.96	0.99	0.99	0.99	0.86	0.66	0.43	0.78	0.36	0.89	0.85
Income Before Tax	0.2	0.33	0.16	0.17	0.36	0.18	0.35	0.17	0.04	0.23	0.35		1.0	0.25	0.3	0.31	0.29	0.21	0.22	0.05	0.16	0.02	0.22	0.27
Total Other Income Expense Net	0.19	0.3	0.13	0.13	0.33	0.15	0.32	0.13	0.02	0.2	0.32	1.0		0.22	0.27	0.28	0.26	0.18	0.21	0.03	0.13	0.0	0.19	0.25
Selling And Marketing Expenses	0.4	0.97	0.94	0.94	0.88	0.95	0.96	0.9	0.47	0.91	0.96	0.25	0.22		0.98	0.98	0.98	0.9	0.51	0.47	0.82	0.41	0.91	0.77
Total Revenue	0.46	1.0	0.93	0.93	0.91	0.93	0.99	0.89	0.42	0.88	0.99	0.3	0.27	0.98		1.0	1.0	0.9	0.62	0.42	0.8	0.37	0.91	0.84
Gross Profit	0.48	1.0	0.92	0.92	0.93	0.92	0.99	0.89	0.4	0.88	0.99	0.31	0.28	0.98	1.0		0.99	0.9	0.61	0.4	0.78	0.34	0.91	0.85
Cost Of Revenue	0.41	0.99	0.94	0.94	0.89	0.95	0.98	0.9	0.45	0.89	0.99	0.29	0.26	0.98	1.0	0.99		0.9	0.65	0.46	0.84	0.43	0.91	0.83
Net Income From Continuing Ops	0.42	0.87	0.97	0.96	0.71	0.95	0.83	1.0	0.18	0.85	0.86	0.21	0.18	0.9	0.9	0.9	0.9		0.5	0.18	0.8	0.39	0.82	0.72
Non Operating Income Net Other	0.21	0.65	0.5	0.54	0.6	0.53	0.64	0.49	0.28	0.45	0.66	0.22	0.21	0.51	0.62	0.61	0.65	0.5		0.28	0.57	0.34	0.51	0.77
Tax Provision	-0.38	0.42	0.4	0.46	0.28	0.46	0.39	0.18	1.0	0.45	0.43	0.05	0.03	0.47	0.42	0.4	0.46	0.18	0.28		0.63	0.73	0.42	0.11
Interest Income	0.03	0.78	0.86	0.91	0.57	0.92	0.72	0.8	0.63	0.9	0.78	0.16	0.13	0.82	0.8	0.78	0.84	0.8	0.57	0.63		0.81	0.68	0.52
Net Interest Income	-0.55	0.34	0.5	0.58	0.08	0.58	0.27	0.4	0.73	0.54	0.36	0.02	0.0	0.41	0.37	0.34	0.43	0.39	0.34	0.73	0.81		0.31	0.01
Reconciled Depreciation	0.37	0.9	0.87	0.86	0.81	0.85	0.89	0.82	0.41	0.74	0.89	0.22	0.19	0.91	0.91	0.91	0.91	0.82	0.51	0.42	0.68	0.31		0.75
Extraordinary Items	0.69	0.86	0.68	0.68	0.91	0.69	0.88	0.71	0.11	0.66	0.85	0.27	0.25	0.77	0.84	0.85	0.83	0.72	0.77	0.11	0.52	0.01	0.75

Click cells to compare fundamentals

DexCom Account Relationship Matchups

DexCom income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	60.3M	84.7M	102M	18.6M	20.3M	15.5M
Other Operating Expenses	1.3B	1.6B	2.2B	2.5B	3.0B	3.2B
Operating Income	142.3M	299.5M	175.4M	391.2M	597.7M	627.6M
Ebit	142.3M	299.5M	175.4M	391.2M	730.7M	767.2M
Research Development	273.5M	359.9M	604.2M	484.2M	505.8M	531.1M
Ebitda	164.5M	382.7M	277.4M	416.9M	916.7M	962.5M
Total Operating Expenses	789.2M	980.6M	1.4B	1.5B	1.7B	1.8B
Net Income	101.1M	493.6M	154.7M	341.2M	541.5M	568.6M
Income Tax Expense	3.1M	(268.6M)	19.2M	49.6M	168.9M	177.3M
Depreciation And Amortization	22.2M	83.2M	102M	25.7M	186M	195.3M
Selling General Administrative	482.6M	544.2M	684.1M	867.2M	1.0B	1.1B
Income Before Tax	104.2M	225M	173.9M	390.8M	710.4M	745.9M
Total Other Income Expense Net	80.1M	(38.1M)	(74.5M)	(1.5M)	(2M)	(2.1M)
Selling And Marketing Expenses	33.1M	76.5M	126.4M	133M	180.8M	189.8M
Total Revenue	1.5B	1.9B	2.4B	2.9B	3.6B	3.8B
Gross Profit	931.5M	1.3B	1.7B	1.9B	2.3B	2.4B
Cost Of Revenue	544.5M	646.6M	768M	1.0B	1.3B	1.4B
Net Income From Continuing Ops	101.1M	493.6M	154.7M	341.2M	541.5M	568.6M
Net Income Applicable To Common Shares	101.1M	493.6M	154.7M	341.2M	392.4M	412.0M
Tax Provision	3.1M	(268.6M)	19.2M	49.6M	168.9M	177.3M
Interest Income	26.4M	16.1M	1.7M	18M	135M	141.8M
Net Interest Income	(33.9M)	(68.6M)	(100.3M)	(18.6M)	114.7M	120.4M
Reconciled Depreciation	48.7M	67.1M	102M	155.9M	186M	95.1M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as DexCom Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:

How To Invest In DexCom

Details

Is DexCom Stock a good investment?

Details

What is DexCom's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Note that the DexCom Inc information on this page should be used as a complementary analysis to other DexCom's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for DexCom Stock analysis

When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.

	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites

Is DexCom's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.987

Earnings Share

1.54

Revenue Per Share

9.827

Quarterly Revenue Growth

0.242

Return On Assets

0.0679

The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

DexCom Historical Income Statement

About DexCom Income Statement Analysis

DexCom Income Statement Chart

Interest Expense

Other Operating Expenses

Total Operating Expenses

Interest Income

DexCom income statement Correlations

DexCom Account Relationship Matchups

High Positive Relationship

High Negative Relationship

DexCom income statement Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for DexCom Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Selling General Administrative	+ 1.0	Other Operating Expenses
Total Revenue	+ 1.0	Other Operating Expenses
Gross Profit	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Net Income From Continuing Ops	+ 1.0	Net Income

Net Interest Income	- 0.55	Interest Expense
Tax Provision	- 0.38	Interest Expense
Income Tax Expense	- 0.38	Interest Expense
Net Interest Income	- 0.0	Total Other Income Expense Net